Cargando…

The utility of SARS‐CoV‐2‐specific serology in COVID‐19 diagnosis

INTRODUCTION: In May 2020, The Communicable Diseases Network of Australia (CDNA) case definition introduced serological criteria to support the diagnosis of severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2). We present findings that support the utility of SARS‐CoV‐2‐specific serology for...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hasan, Tasnim, Lim, H. Ling, Case, Jennifer, Hueston, Linda, Bag, Shopna, Dwyer, Dominic E., O'Sullivan, Matthew V.N.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2021
Materias:	Covid‐19
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8652559/ https://www.ncbi.nlm.nih.gov/pubmed/34761846 http://dx.doi.org/10.1111/1753-6405.13155

Ejemplares similares

SARS-CoV-2-specific IgM screening has low sensitivity for identifying potentially infectious travellers
por: Hasan, Tasnim, et al.
Publicado: (2021)

Asthma and viruses: A focus on rhinoviruses and SARS-CoV-2
por: Padayachee, Yorissa, et al.
Publicado: (2021)

Air filtration and SARS-CoV-2
por: Nazarenko, Yevgen
Publicado: (2020)

Neurological Complications of SARS-CoV, MERS-CoV, and COVID-19
por: Alshebri, Munirah Saad, et al.
Publicado: (2020)

Antidiabetes Agents against Sars-Cov-2 Infection
por: Vitiello, Antonio, et al.
Publicado: (2020)

Re-reading the SARS-COV-2 Epidemic in Bergamo
por: Schena, Daniele, et al.
Publicado: (2020)

Infections sévères à SARS-CoV-2
por: Taghboulit, N., et al.
Publicado: (2021)

Association between stopping universal SARS-CoV-2 admission testing and hospital-onset SARS-CoV-2 in England and Scotland
por: Pak, Theodore, et al.
Publicado: (2023)

The OM-85 bacterial lysate inhibits SARS-CoV-2 infection of epithelial cells by downregulating SARS-CoV-2 receptor expression
por: Pivniouk, Vadim, et al.
Publicado: (2022)

The SARS-CoV-2 Outbreak: an Epidemiological and Clinical Perspective
por: Wong, Rebecca S. Y.
Publicado: (2020)

Diaphragmatic myoclonus due to SARS-CoV-2 infection
por: Borroni, Barbara, et al.
Publicado: (2020)

SARS-CoV-2, an Underestimated Pathogen of the Nervous System
por: Jakhmola, Shweta, et al.
Publicado: (2020)

Nutritional status in post SARS-Cov2 rehabilitation patients
por: Gobbi, M., et al.
Publicado: (2022)

Dysphagia and mechanical ventilation in SARS-COV-2 pneumonia: It's real
por: Bordejé Laguna, Luisa, et al.
Publicado: (2022)

SARS-CoV-2 vaccine-related neurological complications
por: Oonk, Nicol G. M., et al.
Publicado: (2022)

A Cluster of Aspergillosis Associated with SARS-CoV-2
por: VerLee, Kerrie, et al.
Publicado: (2021)

Mitigation Strategies to Reduce Aerosolization of SARS-CoV-2
Publicado: (2022)

Single dose of BNT162b2 mRNA vaccine against severe acute respiratory syndrome coronavirus‐2 (SARS‐CoV‐2) induces neutralising antibody and polyfunctional T‐cell responses in patients with chronic myeloid leukaemia
por: Harrington, Patrick, et al.
Publicado: (2021)

Use of COVID-19 Serologic Testing in Healthcare Workers with Acute Respiratory Tract Infection
por: Ray, Amy
Publicado: (2021)

Viral shedding patterns of symptomatic SARS-CoV-2 infections by periods of variant predominance and vaccination status in Gyeonggi Province, Korea
por: Choi, Gawon, et al.
Publicado: (2022)

The Evidence for High-Titer Convalescent Plasma in SARS-CoV-2
por: Fisher, David L., et al.
Publicado: (2021)

Nationwide seroprevalence of antibodies against SARS-CoV-2 in Israel
por: Reicher, Shay, et al.
Publicado: (2021)

Broken Heart (Takotsubo) Syndrome Triggered by SARS-CoV-2
por: Finsterer, Josef
Publicado: (2021)

Thoracic sarcopenia as a predictive factor of SARS-COV2 evolution
por: Koehler, J., et al.
Publicado: (2022)

Seroepidemiology of SARS-CoV-2, Yamagata, Japan, June 2020
por: Morikane, Keita, et al.
Publicado: (2021)

Cognitive phenotyping of post-infectious SARS-CoV-2 patients
por: Aiello, Edoardo Nicolò, et al.
Publicado: (2022)

Viral Clearance and Serological Response to SARS-CoV-2 in Kidney Transplant Recipients
por: Silvano, Jos.., et al.
Publicado: (2021)

Animal Models to Study Emerging Technologies Against SARS-CoV-2
por: Mullick, Jhinuk Basu, et al.
Publicado: (2020)

Protective Effects of CVD and DM Medications in SARS-CoV-2 Infection
por: Bangi, Shifa, et al.
Publicado: (2020)

SARS-CoV-2-Related Kidney Injury: Current Concern and Challenges
por: Cheng, Yongqian, et al.
Publicado: (2020)

Important Steps to Control COVID-19/SARS-CoV-2 Infection
por: Chatterjee, Sudipto
Publicado: (2020)

First motor seizure as presenting symptom of SARS-CoV-2 infection
por: Fasano, Antonio, et al.
Publicado: (2020)

Geriatric Syndromes and SARS-COV-2: More than Just Being Old
por: Aprahamian, Ivan, et al.
Publicado: (2020)

Potential neurological impact of coronaviruses: implications for the novel SARS-CoV-2
por: Iroegbu, Joy D., et al.
Publicado: (2020)

Reversible conduction block of peroneal nerve associated with SARS-CoV-2
por: Cioffi, Ettore, et al.
Publicado: (2021)

The Janus faces of SARS-COV-2 infection in myasthenia gravis and myasthenic crisis
por: Galassi, Giuliana
Publicado: (2022)

Prevalence of SARS-CoV-2 Antibody in Healthcare Workers in Central Pennsylvania
por: Kwon, Taesung, et al.
Publicado: (2021)

Age-specific contribution of contacts to transmission of SARS-CoV-2 in Germany
por: Rodiah, Isti, et al.
Publicado: (2023)

Real-life Evidence of Lower Lung Virulence in COVID-19 Inpatients Infected with SARS-CoV-2 Omicron Variant Compared to Wild-Type and Delta SARS-CoV-2 Pneumonia
por: Trunfio, Mattia, et al.
Publicado: (2022)

HLA and immunological features of SARS-CoV-2-induced Guillain-Barré syndrome
por: Gigli, Gian Luigi, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_9v7p8dg046c5t053kaps7fca6s